Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Meridian Bioscience (VIVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 09/30

(Values in U.S. thousands)

	06-2020	03-2020	12-2019	09-2019	06-2019
Assets
Current Assets
Cash & Cash Equivalents	63,445	49,550	68,557	62,397	55,192
Receivables	42,384	40,184	35,318	36,698	31,995
Inventories	60,468	41,008	42,827	39,617	43,305
TOTAL	$174,206	$136,589	$152,432	$144,761	$137,389

Non-Current Assets
PPE Net	30,808	30,374	30,495	30,567	31,825
Intangibles	201,930	146,046	148,544	149,484	152,108
Other Non-Current Assets	12,843	6,065	6,657	666	1,114
TOTAL	$245,581	$182,485	$185,696	$180,717	$185,047

Total Assets	$419,787	$319,074	$338,128	$325,478	$322,436

Liabilities
Current Liabilities
Short Term Debt	577	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	13,492	7,879	7,932	7,238	8,381
Accrued Expenses	12,408	9,189	7,359	7,938	6,795
Other current liabilities	5,000	13,656	13,653	N/A	N/A
TOTAL	$43,501	$37,885	$34,853	$20,914	$19,822

Non-Current Liabilities
Long Term Debt	98,824	48,824	75,824	75,824	75,824
Other Non-Current Liabilities	39,416	24,673	27,249	35,251	35,320
TOTAL	$142,951	$76,656	$105,983	$113,597	$114,061

Total Liabilities	$186,452	$114,541	$140,836	$134,511	$133,883

Shareholders' Equity
Shares Outstanding, K	42,863	42,833	42,829	42,742	42,712
Common Shares	N/A	134,584	N/A	N/A	N/A
Retained earnings	102,801	75,294	65,935	63,108	59,005
Other shareholders' equity	-5,100	-5,345	-2,265	-4,975	-2,763
TOTAL	$233,335	$204,533	$197,292	$190,967	$188,553

Total Liabilities And Equity	$419,787	$319,074	$338,128	$325,478	$322,436